JAMES B. BREITMEYER - 03 Jul 2023 Form 4 Insider Report for Oncternal Therapeutics, Inc.

Role
Chief Executive Officer, Director
Signature
/s/Chase C. Leavitt, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
03 Jul 2023
Net transactions value
-$18,720
Form type
4
Filing time
05 Jul 2023, 18:59:54 UTC
Previous filing
17 Apr 2023
Next filing
04 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONCT Common Stock Tax liability $17,277 -47,992 -8.9% $0.3600 493,989 03 Jul 2023 Direct F1
transaction ONCT Common Stock Tax liability $1,443 -4,007 -17% $0.3600 19,911 03 Jul 2023 By Spouse F1
holding ONCT Common Stock 196,544 03 Jul 2023 By Family Trust
holding ONCT Common Stock 733 03 Jul 2023 By Child
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by the Issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units.